Researchers with UNC School of Medicine, Gillings School of Global Health, and Lineberger Comprehensive Cancer Center collaborated on a new study that highlights a simple but effective way to improve…
The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.
Biochemistry, Cancer, Neurology, News, Oncology, Research, Vital Signs
A new study in the lab of Jason Stein, PhD, modeled brain development in a dish to identify cells and genes that influence infant brain growth, a trait associated with…
Geriatrics, News, Psychiatry And Mental Health, Research, Vital Signs
This project is co-led by Dual Principal Investigators Dr. Kori Flower at the University of North Carolina at Chapel Hill and Dr. Eliana Perrin at The Johns Hopkins University.
Clinical Research, News, Pediatrics And Children's Health, Primary Care, Research, Vital Signs
Jason Franz, PhD, professor of biomedical engineering at the UNC School of Medicine, has been awarded a $400,000 grant from NCInnovation to advance groundbreaking research involving wearable sensors and artificial…
A clinical trial led by the UNC School of Medicine weighs medications versus ‘wait and see’ approach for treatment of patent ductus arteriosus.
News, Pediatrics And Children's Health, Research, Vital Signs
UNC researchers discovered how a key step in cell signaling works by showing exactly how G proteins detach from receptors that many common medicines target.
News, Pharmacology, Research, School of Medicine, Vital Signs
The society recognizes distinguished academic leaders, educators, and researchers whose contributions have earned national and international acclaim.
Announcements, Faculty, Global Health, News, Nutrition, Pediatrics And Children's Health, Research, Vital Signs
Breathing wildfire smoke, even briefly, can change the bacteria and immune cells in your lungs, which may contribute to adverse health effects.
UNC School of Medicine researchers led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.
